Abiopharma

🔍 Richmond Raphaell Z. (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 608 shares of Common Shares at $40.95 per share (Direct)
  Date: 2026-06-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 52,012.00 | transaction_form_type: 4
• Sold 317 shares of Common Shares at $40.95 per share (Direct)
  Date: 2026-06-28 | Code: F | equity_swap_involved: 0 | shares_owned_after: 51,695.00 | transaction_form_type: 4
• Acquired 13,671 shares of Common Shares at $24.41 per share (Direct)
  Date: 2026-06-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 65,366.00 | transaction_form_type: 4
• Sold 13,671 shares of Common Shares at $39.8313 per share (Direct)
  Date: 2026-06-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 51,695.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 13,671 shares of Employee Stock Options (right to buy) at $24.41 per share (Derivative)
  Date: 2026-06-29 | Code: M | Expires: 2032-06-28 | Exercise: 2023-06-28 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.78 to $39.93, inclusive. The reporting person undertakes to provide the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F2: These options were granted under the La-Z-Boy Incorporated 2017 Omnibus Incentive Plan and became exercisable in four equal annual installments beginning on the date shown in the Date Exercisable Column.